Exact Sciences
EXAS
#1140
Rank
A$28.08 B
Marketcap
A$147.15
Share price
-0.18%
Change (1 day)
107.86%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): A-$8.54

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is A-$7.55. In 2024 the company made an earnings per share (EPS) of A-$7.90.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$8.548.1%
2024A-$7.90
2022A-$5.022.31%
2021A-$4.91-38.54%
2020A-$7.99692.96%
2019A-$1.01-50.69%
2018A-$2.0444%
2017A-$1.42-39.39%
2016A-$2.34-2.94%
2015A-$2.4137.1%
2014A-$1.7679.71%
2013A-$0.98-21.59%
2012A-$1.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$2.93-138.82%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
A$0.55-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$0.48-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.14-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A-$72.19 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA